CLINICAL TRIALS PROFILE FOR ORAMORPH SR
✉ Email this page to a colleague
All Clinical Trials for ORAMORPH SR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02556970 ↗ | A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery | Withdrawn | David Telling Charitable Trust | N/A | 1969-12-31 | This study seeks to establish if thoracoscopic surgery performed through a single port or incision reduces early post-operative pain compared with conventional multiple port thoracoscopic surgery. This initial pilot study is designed to establish whether a trial of the two techniques is acceptable to patients, clinically feasible and can be delivered in a reasonable timescale. |
NCT02556970 ↗ | A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery | Withdrawn | University Hospitals Bristol and Weston NHS Foundation Trust | N/A | 1969-12-31 | This study seeks to establish if thoracoscopic surgery performed through a single port or incision reduces early post-operative pain compared with conventional multiple port thoracoscopic surgery. This initial pilot study is designed to establish whether a trial of the two techniques is acceptable to patients, clinically feasible and can be delivered in a reasonable timescale. |
NCT02556970 ↗ | A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery | Withdrawn | University Hospitals Bristol NHS Foundation Trust | N/A | 1969-12-31 | This study seeks to establish if thoracoscopic surgery performed through a single port or incision reduces early post-operative pain compared with conventional multiple port thoracoscopic surgery. This initial pilot study is designed to establish whether a trial of the two techniques is acceptable to patients, clinically feasible and can be delivered in a reasonable timescale. |
NCT02869321 ↗ | Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy | Completed | Central Hospital, Nancy, France | Phase 4 | 2015-05-01 | Patients with Head & Neck Squamous Cell Carcinoma often need a gastrostomy. It can be performed with a radiological approach. This procedure is usually not performed under general anesthesia, but local anesthesia is not sufficient to counteract pain due to gastric insufflation and incision of the abdominal wall. Standard analgesic treatments are usually not well-fitted due to onset of action or route of administration. An alternative solution could be fentanyl nasal spray, a treatment with a fast onset of action and with easy use allowing repetition if needed, during the procedure. The purpose of this study is to compare analgesic efficacy of nasal instillation of PECFENT® to usually administered morphinic analgesic treatment with fast onset of action (ORAMORPH®), in radiologic percutaneous gastrostomy tube placement: - during the procedure - following the procedure (measured by Visual Analog Scale (VAS) for Pain at 15 min, 30 min, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours and 12 hours after procedure). Secondary purposes are to compare easiness of 2 treatments and their adverse effects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ORAMORPH SR
Condition Name
Clinical Trial Locations for ORAMORPH SR
Trials by Country
Clinical Trial Progress for ORAMORPH SR
Clinical Trial Phase
Clinical Trial Sponsors for ORAMORPH SR
Sponsor Name